Virax Biolabs Group Limited - Ordinary Shares (VRAX)

Investors in healthcare and biotech sectors should keep an eye on several prominent companies making strides in innovation, clinical trials, and global expansion. Modular Medical (NASDAQ: MODD), Cardiol Therapeutics (NASDAQ: CRDL) , DBV Technologies (NASDAQ: DBVT) , and Virax Biolabs (NASDAQ: VRAX) are key players to watch in the ever-evolving medical landscape. Each company has announced significant developments in technology, trials, and product distribution, solidifying their positions in the market.

Virax Biolabs, Inc. (NASDAQ: VRAX) is engaged as a biotechnology company, which is focused on the prevention, detection and diagnosis

WH recently announced that its expanding monkeypox vaccination efforts. The infection seems to be slowed down in some major cities like New York and Chicago. However, cases seem to be popping in other parts of the country. Greenwood District 50 Schools revised its statement released Wednesday night to classify the incident as a "potential case of moneypox," after a request from the South Carolina Department of Health and Environmental Control. DHEC has not identified the individual. On July 29 New York State governor, Kathy Hochul, declared the monkeypox outbreak a state emergency. On August 2, president Joe Biden named two federal officials, Bob Fenton and Dr. Daskalakis to lead and accelerate the U.S. government's response against monkeypox.

Kits Available in July for Distribution